49 related articles for article (PubMed ID: 25202067)
21. Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways.
Park CH; Han SE; Nam-Goong IS; Kim YI; Kim ES
Endocrinol Metab (Seoul); 2018 Mar; 33(1):121-132. PubMed ID: 29589394
[TBL] [Abstract][Full Text] [Related]
22. Tunicamycin suppresses breast cancer cell growth and metastasis via regulation of the protein kinase B/nuclear factor-κB signaling pathway.
Wang X; Xiong W; Tang Y
Oncol Lett; 2018 Apr; 15(4):4137-4142. PubMed ID: 29541178
[TBL] [Abstract][Full Text] [Related]
23. Paraptosis triggers mitochondrial pathway-mediated apoptosis in Alzheimer's disease.
Jia DP; Wang S; Zhang BC; Fang F
Exp Ther Med; 2015 Aug; 10(2):804-808. PubMed ID: 26622397
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Horm Metab Res; 2013 Jun; 45(6):408-14. PubMed ID: 23386415
[TBL] [Abstract][Full Text] [Related]
25. The hsp70 inhibitor VER155008 induces paraptosis requiring de novo protein synthesis in anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Biochem Biophys Res Commun; 2014 Nov; 454(1):36-41. PubMed ID: 25450359
[TBL] [Abstract][Full Text] [Related]
26. Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
J Endocrinol Invest; 2013 Dec; 36(11):1099-104. PubMed ID: 24084189
[TBL] [Abstract][Full Text] [Related]
27. Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.
Salerno P; De Falco V; Tamburrino A; Nappi TC; Vecchio G; Schweppe RE; Bollag G; Santoro M; Salvatore G
J Clin Endocrinol Metab; 2010 Jan; 95(1):450-5. PubMed ID: 19880792
[TBL] [Abstract][Full Text] [Related]
28. BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein.
Chiappetta G; Basile A; Arra C; Califano D; Pasquinelli R; Barbieri A; De Simone V; Rea D; Giudice A; Pezzullo L; De Laurenzi V; Botti G; Losito S; Conforti D; Turco MC
J Clin Endocrinol Metab; 2012 Jan; 97(1):E115-20. PubMed ID: 22072743
[TBL] [Abstract][Full Text] [Related]
29. Tunicamycin induces paraptosis potentiated by inhibition of BRAFV600E in FRO anaplastic thyroid carcinoma cells.
Kim SH; Shin HY; Kim YS; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Anticancer Res; 2014 Sep; 34(9):4857-68. PubMed ID: 25202067
[TBL] [Abstract][Full Text] [Related]
30. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
31. [Progress of anti-tumor study based on BRAF].
Yan GR; Xu ZJ; Wang HY; Zhu WL
Yao Xue Xue Bao; 2012 Dec; 47(12):1567-74. PubMed ID: 23460959
[TBL] [Abstract][Full Text] [Related]
32. Small-molecule compounds target paraptosis to improve cancer therapy.
Wang Y; Wen X; Zhang N; Wang L; Hao D; Jiang X; He G
Biomed Pharmacother; 2019 Oct; 118():109203. PubMed ID: 31306970
[TBL] [Abstract][Full Text] [Related]
33. Benefits and Pitfalls of a Glycosylation Inhibitor Tunicamycin in the Therapeutic Implication of Cancers.
Banerjee S; Ansari AA; Upadhyay SP; Mettman DJ; Hibdon JR; Quadir M; Ghosh P; Kambhampati A; Banerjee SK
Cells; 2024 Feb; 13(5):. PubMed ID: 38474359
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
